Jos van der Meer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Mononuclear Leukocytes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Sprong Tom; Mollnes Tom Eirik; Neeleman Chris; Swinkels Dorine; Netea Mihai G; van der Meer Jos W M; van Deuren Marcel
Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock.
Ferwerda Bart; Ferwerda Gerben; Plantinga Theo S; Willment Janet A; van Spriel Annemiek B; Venselaar Hanka; Elbers Clara C; Johnson Melissa D; Cambi Alessandra; Huysamen Cristal; Jacobs Liesbeth; Jansen Trees; Verheijen Karlijn; Masthoff Laury; Morré Servaas A; Vriend Gert; Williams David L; Perfect John R; Joosten Leo A B; Wijmenga Cisca; van der Meer Jos W M; Adema Gosse J; Kullberg Bart Jan; Brown Gordon D; Netea Mihai G
Human dectin-1 deficiency and mucocutaneous fungal infections.
Sprong Tom; van der Ven-Jongekrijg Johanna; Neeleman Chris; van der Meer Jos W M; van Deuren Marcel
Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jos van der Meer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sprong Tom; Mollnes Tom Eirik; Neeleman Chris; Swinkels Dorine; Netea Mihai G; van der Meer Jos W M; van Deuren Marcel
Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(9):1380-6.
2009: Ferwerda Bart; Ferwerda Gerben; Plantinga Theo S; Willment Janet A; van Spriel Annemiek B; Venselaar Hanka; Elbers Clara C; Johnson Melissa D; Cambi Alessandra; Huysamen Cristal; Jacobs Liesbeth; Jansen Trees; Verheijen Karlijn; Masthoff Laury; Morré Servaas A; Vriend Gert; Williams David L; Perfect John R; Joosten Leo A B; Wijmenga Cisca; van der Meer Jos W M; Adema Gosse J; Kullberg Bart Jan; Brown Gordon D; Netea Mihai G
Human dectin-1 deficiency and mucocutaneous fungal infections.
The New England journal of medicine 2009;361(18):1760-7.
2009: Sprong Tom; van der Ven-Jongekrijg Johanna; Neeleman Chris; van der Meer Jos W M; van Deuren Marcel
Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.
Critical care medicine 2009;37(10):2812-8.
2009: Bruce Julie; MacKenzie Fiona M; Cookson Barry; Mollison Jill; van der Meer Jos W M; Krcmery Vladimir; Gould Ian M;
Antibiotic stewardship and consumption: findings from a pan-European hospital study.
The Journal of antimicrobial chemotherapy 2009;64(4):853-60.
2009: Knoop Hans; van der Meer Jos W M; Bleijenberg Gijs
Chronic fatigue in Gulf War veterans: should it be treated as chronic fatigue syndrome?
Psychological medicine 2009;39(8):1401-2.
2009: Kleinnijenhuis Johanneke; Joosten Leo A B; van de Veerdonk Frank L; Savage Nigel; van Crevel Reinout; Kullberg Bart Jan; van der Ven Andre; Ottenhoff Tom H M; Dinarello Charles A; van der Meer Jos W M; Netea Mihai G
Transcriptional and inflammasome-mediated pathways for the induction of IL-1beta production by Mycobacterium tuberculosis.
European journal of immunology 2009;39(7):1914-22.
2009: Chai Louis Y A; Kullberg Bart Jan; Vonk Alieke G; Warris Adilia; Cambi Alessandra; Latgé Jean-Paul; Joosten Leo A B; van der Meer Jos W M; Netea Mihai G
Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus.
Infection and immunity 2009;77(5):2184-92.
2009: Suharti Catharina; van Gorp Eric C M; Dolmans Wil M V; Groen Jan; Hadisaputro Suharyo; Djokomoeljanto Robert J; Dme Osterhaus Ab; van der Meer Jos W M
Expression of NF-kB and COX-2 in Young Versus Older Patients with Sporadic Colorectal Cancer.
Acta medica Indonesiana 2009;41(2):75-80.
2009: van de Veerdonk Frank L; Marijnissen Renoud J; Kullberg Bart Jan; Koenen Hans J P M; Cheng Shih-Chin; Joosten Irma; van den Berg Wim B; Williams David L; van der Meer Jos W M; Joosten Leo A B; Netea Mihai G
The macrophage mannose receptor induces IL-17 in response to Candida albicans.
Cell host & microbe 2009;5(4):329-40.
2009: Popa Calin; Netea Mihai G; de Graaf Jacqueline; van den Hoogen Frank H J; Radstake Timothy R D J; Toenhake-Dijkstra Helga; van Riel Piet L C M; van der Meer Jos W M; Stalenhoef Anton F H; Barrera Pilar
Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
The Journal of rheumatology 2009;36(4):724-30.
2009: van de Veerdonk Frank L; Joosten Leo A B; Devesa Isabel; Mora-Montes Héctor M; Kanneganti Thirumala-Devi; Dinarello Charles A; van der Meer Jos W M; Gow Neil A R; Kullberg Bart Jan; Netea Mihai G
Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans.
The Journal of infectious diseases 2009;199(7):1087-96.
2009: Bleeker-Rovers Chantal P; van der Meer Jos W M; Oyen Wim J G
Fever of unknown origin.
Seminars in nuclear medicine 2009;39(2):81-7.
2009: Netea Mihai G; Nold-Petry Claudia A; Nold Marcel F; Joosten Leo A B; Opitz Bastian; van der Meer Jonathan H M; van de Veerdonk Frank L; Ferwerda Gerben; Heinhuis Bas; Devesa Isabel; Funk C Joel; Mason Robert J; Kullberg Bart Jan; Rubartelli Anna; van der Meer Jos W M; Dinarello Charles A
Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.
Blood 2009;113(10):2324-35.
2009: De Lange Floris P; Knoop Hans; Bleijenberg Gijs; Van der Meer Jos W M; Hagoort Peter; Toni Ivan
The experience of fatigue in the brain.
Psychological medicine 2009;39(3):523-4.
2009: Bodar Evelien J; Drenth Joost P H; van der Meer Jos W M; Simon Anna
Dysregulation of innate immunity: hereditary periodic fever syndromes.
British journal of haematology 2009;144(3):279-302.
2009: Ferwerda Bart; McCall Matthew B B; de Vries Maaike C; Hopman Joost; Maiga Boubacar; Dolo Amagana; Doumbo Ogobara; Daou Modibo; de Jong Dirk; Joosten Leo A B; Tissingh Rudi A; Reubsaet Frans A G; Sauerwein Robert; van der Meer Jos W M; van der Ven André J A M; Netea Mihai G
Caspase-12 and the inflammatory response to Yersinia pestis.
PloS one 2009;4(9):e6870.
2009: Netea Mihai G; Joosten Leo A B; Keuter Monique; Wagener Frank; Stalenhoef Anton F H; van der Meer Jos W M; Kullberg Bart Jan
Circulating lipoproteins are a crucial component of host defense against invasive Salmonella typhimurium infection.
PloS one 2009;4(1):e4237.
2008: Bodar Evelien; Netea Mihai G; de Jong Dirk J; Kullberg Bart-Jan; Joosten Leo A B; Van der Meer Jos W M
NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease.
European cytokine network 2008;19(4):185-9.
2008: Netea Mihai G; van de Veerdonk Frank L; Kullberg Bart Jan; Van der Meer Jos W M; Joosten Leo A B
The role of NLRs and TLRs in the activation of the inflammasome.
Expert opinion on biological therapy 2008;8(12):1867-72.
2008: van der Hilst Jeroen C H; Bodar Evelien J; Barron Karyl S; Frenkel Joost; Drenth Joost P H; van der Meer Jos W M; Simon Anna;
Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.
Medicine 2008;87(6):301-10.
2008: Knoop Hans; van der Meer Jos W M; Bleijenberg Gijs
Guided self-instructions for people with chronic fatigue syndrome: randomised controlled trial.
The British journal of psychiatry : the journal of mental science 2008;193(4):340-1.
2008: Matera Giovanni; Liberto Maria Carla; Joosten Leo A B; Vinci Maria; Quirino Angela; Pulicari Maria Concetta; Kullberg Bart Jan; Van der Meer Jos W M; Netea Mihai G; Focà Alfredo
The Janus face of Bartonella quintana recognition by Toll-like receptors (TLRs): a review.
European cytokine network 2008;19(3):113-8.
2008: de Lange Floris P; Koers Anda; Kalkman Joke S; Bleijenberg Gijs; Hagoort Peter; van der Meer Jos W M; Toni Ivan
Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome.
Brain : a journal of neurology 2008;131(Pt 8):2172-80.
2008: Veenemans Jacobien; Andang'o Pauline E A; Mbugi Erasto V; Kraaijenhagen Rob J; Mwaniki David L; Mockenhaupt Frank P; Roewer Susanne; Olomi Raimos M; Shao John F; van der Meer Jos W M; Savelkoul Huub F J; Verhoef Hans
Alpha+ -thalassemia protects against anemia associated with asymptomatic malaria: evidence from community-based surveys in Tanzania and Kenya.
The Journal of infectious diseases 2008;198(3):401-8.
2008: Joosten Leo A B; Heinhuis Bas; Abdollahi-Roodsaz Shahla; Ferwerda Gerben; Lebourhis Lionel; Philpott Dana J; Nahori Marie-Anne; Popa Calin; Morre Servaas A; van der Meer Jos W M; Girardin Stephen E; Netea Mihai G; van den Berg Wim B
Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(26):9017-22.
2008: Timen Aura; Hulscher Marlies E J L; Vos Dieuwke; van de Laar Marita J W; Fenton Kevin A; van Steenbergen Jim E; van der Meer Jos W M; Grol Richard P T M
Control measures used during lymphogranuloma venereum outbreak, Europe.
Emerging infectious diseases 2008;14(4):573-8.
2008: Simon Anna; Kullberg Bart Jan; Tripet Brian; Boerman Otto C; Zeeuwen Patrick; van der Ven-Jongekrijg Johanna; Verweij Paul; Schalkwijk Joost; Hodges Robert; van der Meer Jos W M; Netea Mihai G
Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.
Antimicrobial agents and chemotherapy 2008;52(4):1407-12.
2008: Kullberg Bart Jan; Ferwerda Gerben; de Jong Dirk J; Drenth Joost P H; Joosten Leo A B; Van der Meer Jos W M; Netea Mihai G
Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli.
Immunology 2008;123(4):600-5.
2008: Ferwerda Gerben; Kramer Matthijs; de Jong Dirk; Piccini Alessandra; Joosten Leo A; Devesaginer Isabel; Girardin Stephen E; Adema Gosse J; van der Meer Jos W M; Kullberg Bart-Jan; Rubartelli Anna; Netea Mihai G
Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
European journal of immunology 2008;38(1):184-91.
2008: Netea Mihai G; van de Veerdonk Frank; Verschueren Ineke; van der Meer Jos W M; Kullberg Bart Jan
Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.
FEMS immunology and medical microbiology 2008;52(1):118-23.
2008: van de Veerdonk Frank Leo; Netea Mihai G; Jansen Trees J; Jacobs Liesbeth; Verschueren Ineke; van der Meer Jos W M; Kullberg Bart Jan
Redundant role of TLR9 for anti-Candida host defense.
Immunobiology 2008;213(8):613-20.
2007: de Koning Heleen D; Bodar Evelien J; van der Meer Jos W M; Simon Anna;
Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment.
Seminars in arthritis and rheumatism 2007;37(3):137-48.
2007: Gow Neil A R; Netea Mihai G; Munro Carol A; Ferwerda Gerben; Bates Steven; Mora-Montes Héctor M; Walker Louise; Jansen Trees; Jacobs Liesbeth; Tsoni Vicky; Brown Gordon D; Odds Frank C; Van der Meer Jos W M; Brown Alistair J P; Kullberg Bart Jan
Immune recognition of Candida albicans beta-glucan by dectin-1.
The Journal of infectious diseases 2007;196(10):1565-71.
2007: Popa Calin; van den Hoogen Frank H J; Radstake Timothy R D J; Netea Mihai G; Eijsbouts Agnes E; den Heijer Martin; van der Meer Jos W M; van Riel Piet L C M; Stalenhoef Anton F H; Barrera Pilar
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(11):1503-7.
2007: Ferwerda Bart; McCall Matthew B B; Alonso Santos; Giamarellos-Bourboulis Evangelos J; Mouktaroudi Maria; Izagirre Neskuts; Syafruddin Din; Kibiki Gibson; Cristea Tudor; Hijmans Anneke; Hamann Lutz; Israel Shoshana; ElGhazali Gehad; Troye-Blomberg Marita; Kumpf Oliver; Maiga Boubacar; Dolo Amagana; Doumbo Ogobara; Hermsen Cornelus C; Stalenhoef Anton F H; van Crevel Reinout; Brunner Han G; Oh Djin-Ye; Schumann Ralf R; de la Rúa Concepcion; Sauerwein Robert; Kullberg Bart-Jan; van der Ven André J A M; van der Meer Jos W M; Netea Mihai G
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(42):16645-50.
2007: Ferwerda Gerben; Kullberg Bart Jan; de Jong Dirk J; Girardin Stephen E; Langenberg Dennis M L; van Crevel Reinout; Ottenhoff Tom H M; Van der Meer Jos W M; Netea Mihai G
Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.
Journal of leukocyte biology 2007;82(4):1011-8.
2007: Popa Calin; Abdollahi-Roodsaz Shahla; Joosten Leo A B; Takahashi Nozomi; Sprong Tom; Matera Giovanni; Liberto Maria Carla; Foca Alfredo; van Deuren Marcel; Kullberg Bart Jan; van den Berg Wim B; van der Meer Jos W M; Netea Mihai G
Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4.
Infection and immunity 2007;75(10):4831-7.
2007: Abdollahi-Roodsaz Shahla; Joosten Leo A B; Roelofs Mieke F; Radstake Timothy R D J; Matera Giovanni; Popa Calin; van der Meer Jos W M; Netea Mihai G; van den Berg Wim B
Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.
Arthritis and rheumatism 2007;56(9):2957-67.
2007: Knoop Hans; Stulemeijer Maja; Prins Judith B; van der Meer Jos W M; Bleijenberg Gijs
Is cognitive behaviour therapy for chronic fatigue syndrome also effective for pain symptoms?
Behaviour research and therapy 2007;45(9):2034-43.
2007: Alisjahbana Bachti; Sahiratmadja Edhyana; Nelwan Erni J; Purwa Anugrah Maya; Ahmad Yana; Ottenhoff Tom H M; Nelwan Ronald H H; Parwati Ida; van der Meer Jos W M; van Crevel Reinout
The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(4):428-35.
2007: MacKenzie Fiona M; Gould Ian M; Bruce Julie; Mollison Jill; Monnet Dominique L; Krcmery Vladimir; Cookson Barry; van der Meer Jos W M
The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
The Journal of hospital infection 2007;65 Suppl 2():73-81.
2007: Sprong Tom; Pickkers Peter; Geurts-Moespot Anneke; van der Ven-Jongekrijg Johanna; Neeleman Chris; Knaup Marlies; Leroy Didier; Calandra Thierry; van der Meer Jos W M; Sweep Fred; van Deuren Marcel
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Shock (Augusta, Ga.) 2007;27(5):482-7.
2007: Buijs Jacqueline; Dofferhoff Anthonius S M; Mouton Johan W; van der Meer Jos W M
Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
The Journal of antimicrobial chemotherapy 2007;59(5):926-33.
2007: Bleeker-Rovers Chantal P; Vos Fidel J; Mudde Aart H; Dofferhoff Anton S M; de Geus-Oei Lioe-Fee; Rijnders Anton J; Krabbe Paul F M; Corstens Frans H M; van der Meer Jos W M; Oyen Wim J G
A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.
European journal of nuclear medicine and molecular imaging 2007;34(5):694-703.
2007: Schouten Jeroen A; Hulscher Marlies E J L; Natsch Stephanie; Kullberg Bart-Jan; van der Meer Jos W M; Grol Richard P T M
Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.
Quality & safety in health care 2007;16(2):143-9.
2007: Knoop Hans; Prins Judith B; Stulemeijer Maja; van der Meer Jos W M; Bleijenberg Gijs
The effect of cognitive behaviour therapy for chronic fatigue syndrome on self-reported cognitive impairments and neuropsychological test performance.
Journal of neurology, neurosurgery, and psychiatry 2007;78(4):434-6.
2007: Schouten Jeroen A; Hulscher Marlies E J L; Trap-Liefers Janine; Akkermans Reinier P; Kullberg Bart-Jan; Grol Richard P T M; van der Meer Jos W M
Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(7):931-41.
2007: Popa Calin; Netea Mihai G; van Riel Piet L C M; van der Meer Jos W M; Stalenhoef Anton F H
The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.
Journal of lipid research 2007;48(4):751-62.
2007: Bleeker-Rovers Chantal P; Rennen Huub J J M; Boerman Otto C; Wymenga Ate B; Visser Eric P; Bakker Johannes H; van der Meer Jos W M; Corstens Frans H M; Oyen Wim J G
99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(3):337-43.
2007: Bodar Evelien J; van der Hilst Jeroen C H; van Heerde Waander; van der Meer Jos W M; Drenth Joost P H; Simon Anna
Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome.
Blood 2007;109(6):2416-8.
2007: Sahiratmadja Edhyana; Alisjahbana Bachti; de Boer Tjitske; Adnan Iskandar; Maya Anugrah; Danusantoso Halim; Nelwan Ronald H H; Marzuki Sangkot; van der Meer Jos W M; van Crevel Reinout; van de Vosse Esther; Ottenhoff Tom H M
Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
Infection and immunity 2007;75(2):820-9.
2007: Bleeker-Rovers Chantal P; Vos Fidel J; de Kleijn Elisabeth M H A; Mudde Aart H; Dofferhoff Ton S M; Richter Clemens; Smilde Tineke J; Krabbe Paul F M; Oyen Wim J G; van der Meer Jos W M
A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.
Medicine 2007;86(1):26-38.
2007: Simon Anna; van der Meer Jos W M
Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;292(1):R86-98.
2007: The Gerard K H; Bleijenberg Gijs; van der Meer Jos W M
The effect of acclydine in chronic fatigue syndrome: a randomized controlled trial.
PLoS clinical trials 2007;2(5):e19.
2007: Karyadi Elvina; Dolmans Wil M V; West Clive E; Van Crevel Reinout; Nelwan Ronald H H; Amin Zulkifli; Gross Rainer; Van der Ven-Jongekrijg Johanna; Van der Meer Jos W M
Cytokines related to nutritional status in patients with untreated pulmonary tuberculosis in Indonesia.
Asia Pacific journal of clinical nutrition 2007;16(2):218-26.
2007: Knoop Hans; Bleijenberg Gijs; Gielissen Marieke F M; van der Meer Jos W M; White Peter D
Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome?
Psychotherapy and psychosomatics 2007;76(3):171-6.
2007: Setiati Tatty E; Mairuhu Albert T A; Koraka Penelopie; Supriatna Mohamed; Mac Gillavry Melvin R; Brandjes Dees P M; Osterhaus Albert D M E; van der Meer Jos W M; van Gorp Eric C M; Soemantri Augustinus
Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system.
BMC infectious diseases 2007;7():22.
2006: Ferwerda Gerben; Girardin Stephen E; van der Meer Jos W M; Netea Mihai G
Normal responses to specific NOD1 ligands.
European journal of immunology 2006;36(10):2817-8; author reply 2818.
2006: Netea Mihai G; van der Meer Jos W M; Kullberg Bart-Jan
Both TLR2 and TLR4 are involved in the recognition of Candida albicans. Reply to "TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae" by Gil and Gozalbo, Microbes and Infection 8 (2006) 2823-2824.
Microbes and infection / Institut Pasteur 2006;8(12-13):2821-2; author reply 2823-4.
2006: Vonk Alieke G; Netea Mihai G; van der Meer Jos W M; Kullberg Bart Jan
Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.
Expert opinion on biological therapy 2006;6(9):891-903.
2006: Drenth Joost P H; van der Meer Jos W M
The inflammasome--a linebacker of innate defense.
The New England journal of medicine 2006;355(7):730-2.
2006: Netea Mihai G; van der Meer Jos W M; Ferwerda Gerben; Kullberg Bart Jan
Defective acute inflammation in Crohn's disease.
Lancet 2006;368(9535):577-8.
2006: Finck Anemone; Van der Meer Jos W M; Schäffer Alejandro A; Pfannstiel Jessica; Fieschi Claire; Plebani Alessandro; Webster A David B; Hammarström Lennart; Grimbacher Bodo
Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q.
European journal of human genetics : EJHG 2006;14(7):867-75.
2006: Netea Mihai G; Joosten Leo A B; Lewis Eli; Jensen Dalan R; Voshol Peter J; Kullberg Bart Jan; Tack Cees J; van Krieken Han; Kim Soo-Hyun; Stalenhoef Anton F; van de Loo Fons A; Verschueren Ineke; Pulawa Leslie; Akira Shizuo; Eckel Robert H; Dinarello Charles A; van den Berg Wim; van der Meer Jos W M
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.
Nature medicine 2006;12(6):650-6.
2006: Netea Mihai G; Gow Neil A R; Munro Carol A; Bates Steven; Collins Claire; Ferwerda Gerben; Hobson Richard P; Bertram Gwyneth; Hughes H Bleddyn; Jansen Trees; Jacobs Liesbeth; Buurman Ed T; Gijzen Karlijn; Williams David L; Torensma Ruurd; McKinnon Alistair; MacCallum Donna M; Odds Frank C; Van der Meer Jos W M; Brown Alistair J P; Kullberg Bart Jan
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors.
The Journal of clinical investigation 2006;116(6):1642-50.
2006: Vonk Alieke G; Netea Mihai G; van Krieken Johan H; Iwakura Yoichiro; van der Meer Jos W M; Kullberg Bart Jan
Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
The Journal of infectious diseases 2006;193(10):1419-26.
2006: Van der Graaf Chantal A A; Netea Mihai G; Morré Servaas A; Den Heijer Martin; Verweij Paul E; Van der Meer Jos W M; Kullberg Bart Jan
Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.
European cytokine network 2006;17(1):29-34.
2006: van der Graaf Chantal A A; Netea Mihai G; Franke Barbara; Girardin Stephen E; van der Meer Jos W M; Kullberg Bart Jan
Nucleotide oligomerization domain 2 (Nod2) is not involved in the pattern recognition of Candida albicans.
Clinical and vaccine immunology : CVI 2006;13(3):423-5.
2006: de Bont Natasja; Netea Mihai G; Rovers Chantal; Smilde Tineke; Hijmans Anneke; Demacker Pierre N M; van der Meer Jos W M; Stalenhoef Anton F H
LPS-induced release of IL-1 beta, IL-1Ra, IL-6, and TNF-alpha in whole blood from patients with familial hypercholesterolemia: no effect of cholesterol-lowering treatment.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(2):101-7.
2006: Prins Judith B; van der Meer Jos W M; Bleijenberg Gijs
Chronic fatigue syndrome.
Lancet 2006;367(9507):346-55.
2006: Netea Mihai G; Ferwerda Gerben; van der Graaf Chantal A A; Van der Meer Jos W M; Kullberg Bart Jan
Recognition of fungal pathogens by toll-like receptors.
Current pharmaceutical design 2006;12(32):4195-201.
2005: Bleeker-Rovers Chantal P; Vos Fidel J; Wanten Geert J A; van der Meer Jos W M; Corstens Frans H M; Kullberg Bart-Jan; Oyen Wim J G
18F-FDG PET in detecting metastatic infectious disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2014-9.
2005: Ferwerda Gerben; Girardin Stephen E; Kullberg Bart-Jan; Le Bourhis Lionel; de Jong Dirk J; Langenberg Dennis M L; van Crevel Reinout; Adema Gosse J; Ottenhoff Tom H M; Van der Meer Jos W M; Netea Mihai G
NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis.
PLoS pathogens 2005;1(3):279-85.
2005: van der Graaf Chantal A A; Netea Mihai G; Verschueren Ineke; van der Meer Jos W M; Kullberg Bart Jan
Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.
Infection and immunity 2005;73(11):7458-64.
2005: Bazelmans Ellen; Bleijenberg Gijs; Voeten Marinus J M; van der Meer Jos W M; Folgering Hans
Impact of a maximal exercise test on symptoms and activity in chronic fatigue syndrome.
Journal of psychosomatic research 2005;59(4):201-8.
2005: Netea Mihai G; Van der Meer Jos W M; Sutmuller Roger P; Adema Gosse J; Kullberg Bart-Jan
From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.
Antimicrobial agents and chemotherapy 2005;49(10):3991-6.
2005: Netea Mihai G; Ferwerda Gerben; de Jong Dirk J; Werts Catherine; Boneca Ivo G; Jéhanno Muguette; Van Der Meer Jos W M; Mengin-Lecreulx Dominique; Sansonetti Philippe J; Philpott Dana J; Dharancy Sébastien; Girardin Stephen E
The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
The Journal of biological chemistry 2005;280(43):35859-67.
2005: Popa Calin; Barrea Pilar; Netea Mihai G; Stalenhoef Anton F H; van der Meer Jos W M
Anti-TNF therapy and plasma HDL cholesterol concentration.
Atherosclerosis 2005;182(2):375; author reply 377.
2005: Grebenchtchikov Nicolai; van der Ven-Jongekrijg Johanna; Pesman Gerard J; Geurts-Moespot Anneke; van der Meer Jos W M; Sweep Fred C G J
Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies.
European cytokine network 2005;16(3):215-22.
2005: Mairuhu Albert T A; Peri Giuseppe; Setiati Tatty E; Hack C Erik; Koraka Penelopie; Soemantri Augustinus; Osterhaus Albert D M E; Brandjes Dees P M; van der Meer Jos W M; Mantovani Alberto; van Gorp Eric C M
Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections.
Journal of medical virology 2005;76(4):547-52.
2005: van Lettow Monique; van der Meer Jos W M; West Clive E; van Crevel Reinout; Semba Richard D
Interleukin-6 and human immunodeficiency virus load, but not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi.
The Journal of clinical endocrinology and metabolism 2005;90(8):4771-6.
2005: de Lange Floris P; Kalkman Joke S; Bleijenberg Gijs; Hagoort Peter; van der Meer Jos W M; Toni Ivan
Gray matter volume reduction in the chronic fatigue syndrome.
NeuroImage 2005;26(3):777-81.
2005: van der Graaf Chantal; Kullberg Bart Jan; Joosten Leo; Verver-Jansen Trees; Jacobs Liesbeth; Van der Meer Jos W M; Netea Mihai G
Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism.
Cytokine 2005;30(5):264-8.
2005: Netea Mihai G; Ferwerda Gerben; de Jong Dirk J; Jansen Trees; Jacobs Liesbeth; Kramer Matthijs; Naber Ton H J; Drenth Joost P H; Girardin Stephen E; Kullberg Bart Jan; Adema Gosse J; Van der Meer Jos W M
Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(10):6518-23.
2005: Simon Anna; van der Meer Jos W M; Drenth Joost P H
Familial Mediterranean fever--a not so unusual cause of abdominal pain.
Best practice & research. Clinical gastroenterology 2005;19(2):199-213.
2005: Popa Calin; Netea Mihai G; Barrera Pilar; Radstake Timothy R D S; van Riel Piet L; Kullberg Bart-Jan; Van der Meer Jos W M
Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
Cytokine 2005;30(2):72-7.
2005: Stuyt Rogier J L; Netea Mihai G; Verschueren Ineke; Dinarello Charles A; Kullberg Bart Jan; van der Meer Jos W M
Interleukin-18 does not modulate the acute-phase response.
Journal of endotoxin research 2005;11(2):85-8.
2004: Netea Mihai G; Brouwer Annemarie E; Hoogendoorn Elizabeth H; Van der Meer Jos W M; Koolen Marianne; Verweij Paul E; Kullberg Bart Jan
Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(9):e83-7.
2004: Netea Mihai G; Van der Meer Jos W M; Kullberg Bart-Jan
Toll-like receptors as an escape mechanism from the host defense.
Trends in microbiology 2004;12(11):484-8.
2004: Sprong Tom; Jack Dominic L; Klein Nigel J; Turner Malcolm W; van der Ley Peter; Steeghs Liana; Jacobs Liesbeth; van der Meer Jos W M; van Deuren Marcel
Mannose binding lectin enhances IL-1beta and IL-10 induction by non-lipopolysaccharide (LPS) components of Neisseria meningitidis.
Cytokine 2004;28(2):59-66.
2004: Netea Mihai G; Gijzen Karlijn; Coolen Neeltje; Verschueren Ineke; Figdor Carl; Van der Meer Jos W M; Torensma Ruurd; Kullberg Bart Jan
Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages.
Microbes and infection / Institut Pasteur 2004;6(11):985-9.
2004: Bleeker-Rovers Chantal P; Corstens Frans H M; Van Der Meer Jos W M; Oyen Wim J G
Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.
European journal of nuclear medicine and molecular imaging 2004;31(9):1342-3; author reply 1344.
2004: de Lange Floris P; Kalkman Joke S; Bleijenberg Gijs; Hagoort Peter; van der Werf Sieberen P; van der Meer Jos W M; Toni Ivan
Neural correlates of the chronic fatigue syndrome--an fMRI study.
Brain : a journal of neurology 2004;127(Pt 9):1948-57.
2004: Vonk Alieke G; De Bont Natasja; Netea Mihai G; Demacker Pierre N M; van der Meer Jos W M; Stalenhoef Anton F H; Kullberg Bart Jan
Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2004;42(4):341-8.
2004: Simon Anna; Bodar Evelien J; van der Hilst Jeroen C H; van der Meer Jos W M; Fiselier Theo J W; Cuppen Marcel P J M; Drenth Joost P H
Beneficial response to interleukin 1 receptor antagonist in traps.
The American journal of medicine 2004;117(3):208-10.
2004: Netea Mihai G; Kullberg Bart Jan; Jacobs Liesbeth E H; Verver-Jansen Trees J G; van der Ven-Jongekrijg Johanna; Galama Jochem M D; Stalenhoef Anton F H; Dinarello Charles A; Van der Meer Jos W M
Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(2):1477-82.
2004: Netea Mihai G; Kullberg Bart Jan; de Jong Dirk J; Franke Barbara; Sprong Tom; Naber Ton H J; Drenth Joost P H; Van der Meer Jos W M
NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
European journal of immunology 2004;34(7):2052-9.
2004: Volman Thomas J H; Goris R Jan A; van der Meer Jos W M; Hendriks Thijs
Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome.
Annals of surgery 2004;240(1):142-50.
2004: van Mirre Edwin; Teeling Jessica L; van der Meer Jos W M; Bleeker Wim K; Hack C Erik
Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(1):332-9.
2004: Vogtländer Nils P J; Van Kasteren Marjo E E; Natsch Stephanie; Kullberg Bart-Jan; Hekster Yechiel A; Van Der Meer Jos W M
Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy.
Archives of internal medicine 2004;164(11):1206-12.
2004: Sprong Tom; Møller Anne-Sophie W; Bjerre Anna; Wedege Elisabeth; Kierulf Peter; van der Meer Jos W M; Brandtzaeg Petter; van Deuren Marcel; Mollnes T E
Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide.
Infection and immunity 2004;72(6):3344-9.
2004: Simon Anna; Drewe Elizabeth; van der Meer Jos W M; Powell Richard J; Kelley Richard I; Stalenhoef Anton F H; Drenth Joost P H
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
Clinical pharmacology and therapeutics 2004;75(5):476-83.
2004: Netea Mihai G; van der Graaf Chantal; Van der Meer Jos W M; Kullberg Bart Jan
Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
Journal of leukocyte biology 2004;75(5):749-55.
2004: van der Meer Jos W M; Lamberts Steven W J; Buchwald Dedra
Dr Baschetti rides/writes again.
European journal of clinical investigation 2004;34(4):317; author reply 318-9.
2004: Stuyt Rogier J L; Netea Mihai G; van Krieken Johan H; van der Meer Jos W M; Kullberg Bart Jan
Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
The Journal of infectious diseases 2004;189(8):1524-7.
2004: Sprong Tom; Netea Mihai G; van der Ley Peter; Verver-Jansen Trees J G; Jacobs Liesbeth E H; Stalenhoef Anton; van der Meer Jos W M; van Deuren Marcel
Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria.
Journal of lipid research 2004;45(4):742-9.
2004: Netea Mihai G; Sutmuller Roger; Hermann Corinna; Van der Graaf Chantal A A; Van der Meer Jos W M; van Krieken Johan H; Hartung Thomas; Adema Gosse; Kullberg Bart Jan
Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(6):3712-8.
2004: Bleeker-Rovers Chantal P; Bredie Sebastian J H; van der Meer Jos W M; Corstens Frans H M; Oyen Wim J G
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
The American journal of medicine 2004;116(1):50-3.
2004: Bleeker-Rovers Chantal P; de Kleijn Elisabeth M H A; Corstens Frans H M; van der Meer Jos W M; Oyen Wim J G
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
European journal of nuclear medicine and molecular imaging 2004;31(1):29-37.
2004: Netea Mihai G; Kullberg Bart-Jan; Van der Meer Jos W M
Proinflammatory cytokines in the treatment of bacterial and fungal infections.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2004;18(1):9-22.
2003: Bischoff Erik W M A; Soetekouw Patricia M M B; De Vries Maaike; Scheepers Paul T I; Bleijenberg Gijs; van der Meer Jos W M
Chemical sensitivity in symptomatic Cambodia veterans.
Archives of environmental health 2003;58(12):740-5.
2003: van der Speck H; van der Meer J W; Overbeke A J; Hart W
[Clinical reasoning and decision making in practice. A man with pneumonia and ill smelling watery sputum: the truth revealed after 80 years]
Nederlands tijdschrift voor geneeskunde 2003;147(51):2509-13.
2003: Vonk Alieke G; Netea Mihai G; van Krieken Johan H; Verweij Paul E; van der Meer Jos W M; Kullberg Bart Jan
Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.
Antimicrobial agents and chemotherapy 2003;47(12):3688-93.
2003: Netea Mihai G; Vonk Alieke G; van den Hoven Mabel; Verschueren Ineke; Joosten Leo A; van Krieken Johan H; van den Berg Wim B; Van der Meer Jos W M; Kullberg Bart Jan
Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection.
European journal of immunology 2003;33(12):3409-17.
2003: Stuyt Rogier J L; Netea Mihai G; Geijtenbeek Teunis B H; Kullberg Bart Jan; Dinarello Charles A; van der Meer Jos W M
Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes.
Immunology 2003;110(3):329-34.
2003: Sprong Tom; Brandtzaeg Petter; Fung Michael; Pharo Anne M; Høiby E Arne; Michaelsen Terje E; Aase Audun; van der Meer Jos W M; van Deuren Marcel; Mollnes Tom E
Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.
Blood 2003;102(10):3702-10.
2003: van der Meer J W; van de Kerkhof R; The G K; Boers G H
[Hemopyrrollactamuria (HPU); from spots to pseudo-disease]
Nederlands tijdschrift voor geneeskunde 2003;147(36):1720-1.
2003: Suharti Catharina; van Gorp Eric C M; Dolmans Wil M V; Setiati Tatty E; Hack C Erik; Djokomoeljanto Robert; van der Meer Jos W M
Cytokine patterns during dengue shock syndrome.
European cytokine network 2003;14(3):172-7.
2003: Netea Mihai G; Warris Adilia; Van der Meer Jos W M; Fenton Matthew J; Verver-Janssen Trees J G; Jacobs Liesbeth E H; Andresen Tonje; Verweij Paul E; Kullberg Bart Jan
Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction.
The Journal of infectious diseases 2003;188(2):320-6.
2003: Netea Mihai G; Radstake Timothy; Joosten Leo A; van der Meer Jos W M; Barrera Pilar; Kullberg Bart Jan
Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.
Arthritis and rheumatism 2003;48(7):1853-7.
2003: Brouwers Frederieke M; Oyen Wim J G; Boerman Otto C; Barrett John A; Verheugt Freek W A; Corstens Frans H M; Van der Meer Jos W M
Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis.
Clinical nuclear medicine 2003;28(6):480-4.
2003: Netea Mihai G; van der Meer Jos W M; van Deuren Marcel; Kullberg Bart Jan
Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing?
Trends in immunology 2003;24(5):254-8.
2003: Gasem M Hussein; Keuter Monique; Dolmans Wil M V; Van Der Ven-Jongekrijg Johanna; Djokomoeljanto Robert; Van Der Meer Jos W M
Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever.
Antimicrobial agents and chemotherapy 2003;47(5):1727-31.
2003: Wieringa Frank T; Dijkhuizen Marjoleine A; West Clive E; Thurnham David I; Muhilal; Van der Meer Jos W M
Redistribution of vitamin A after iron supplementation in Indonesian infants.
The American journal of clinical nutrition 2003;77(3):651-7.
2003: Simon Anna; Mariman Edwin C; van der Meer Jos W M; Drenth Joost P H
A founder effect in the hyperimmunoglobulinemia D and periodic fever syndrome.
The American journal of medicine 2003;114(2):148-52.
2003: Stuyt Rogier J L; Kim Soo-Hyun; Reznikov Leonid L; Fantuzzi Giamila; Novick Daniela; Rubinstein Menachem; Kullberg Bart Jan; van der Meer Jos W M; Dinarello Charles A; Netea Mihai G
Regulation of Staphylococcus epidermidis-induced IFN-gamma in whole human blood: the role of endogenous IL-18, IL-12, IL-1, and TNF.
Cytokine 2003;21(2):65-73.
2003: Wieringa Frank T; Dijkhuizen Marjoleine A; van der Ven-Jongekrijg Johanna; West Clive E; Muhilal; van der Meer Jos W M
Micronutrient deficiency and supplementation in Indonesian infants. Effects on immune function.
Advances in experimental medicine and biology 2003;531():369-77.
2003: van Crevel Reinout; Ottenhoff Tom H M; van der Meer Jos W M
Innate immunity to Mycobacterium tuberculosis.
Advances in experimental medicine and biology 2003;531():241-7.
2003: Alisjahbana Bachti; Netea Mihai G; van der Meer Jos W M
Pro-inflammatory cytokine response in acute infection.
Advances in experimental medicine and biology 2003;531():229-40.
2002: Pickkers Peter; Netea Mihai G; van der Meer Jos W M; Smits Paul
TNFalpha and IL-1beta exert no direct vasoactivity in human isolated resistance arteries.
Cytokine 2002;20(5):244-6.
2002: Vonk Alieke G; Netea Mihai G; van Krieken Johan H; van der Meer Jos W M; Kullberg Bart Jan
Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha- and lymphotoxin-alpha-deficient mice.
The Journal of infectious diseases 2002;186(12):1815-22.
2002: Sprong Tom; van der Ley Peter; Steeghs Liana; Taw Will J; Verver-Janssen Trees J W; Netea Mihai G; van der Meer Jos W M; van Deuren Marcel
Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.
European cytokine network 2002;13(4):411-7.
2002: Blok Willem L; Rabinovitch Michel; Zilberfarb Vladimir; Netea Mihai G; Buurman Wim A; van der Meer Jos W M
The influence of dietary fish-oil supplementation on cutaneous Leishmania amazonensis infection in mice.
Cytokine 2002;19(5):213-7.
2002: de Vries Maaike; Soetekouw Patricia M M B; van der Meer Jos W M; Bleijenberg Gijs
The role of post-traumatic stress disorder symptoms in fatigued Cambodia veterans.
Military medicine 2002;167(9):790-4.
2002: van der Werf Sieberen P; de Vree Berna; Alberts Maurice; van der Meer Jos W M; Bleijenberg Gijs;
Natural course and predicting self-reported improvement in patients with chronic fatigue syndrome with a relatively short illness duration.
Journal of psychosomatic research 2002;53(3):749-53.
2002: Van Gorp Eric C M; Setiati Tatty E; Mairuhu Albert T A; Suharti Catharina; Cate Ht Hugo ten; Dolmans Wil M V; Van Der Meer Jos W M; Hack C Erik; Brandjes Dees P M
Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever.
Journal of medical virology 2002;67(4):549-54.
2002: Netea Mihai G; Kullberg Bart Jan; Demacker Pierre N M; Jacobs Liesbeth E H; Verver-Jansen Trees J G; Hijmans Anneke; van Tits Lambertus H J; Hoenderop Joost G J; Willems Peter H G M; Van der Meer Jos W M; Stalenhoef Anton F H
Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells.
Journal of lipid research 2002;43(7):1065-71.
2002: Stuyt Rogier J L; Netea Mihai G; Verschueren Ineke; Fantuzzi Giamila; Dinarello Charles A; Van Der Meer Jos W M; Kullberg Bart Jan
Role of interleukin-18 in host defense against disseminated Candida albicans infection.
Infection and immunity 2002;70(6):3284-6.
2002: van der Meer Jos W M
Should we do away with case reports?
The Netherlands journal of medicine 2002;60(4):161.
2002: Prins Judith B; Bleijenberg Gijs; van der Meer Jos W M
Chronic fatigue syndrome and myalgic encephalomyelitis.
Lancet 2002;359(9318):1699.
2002: Netea Mihai G; Van Der Graaf Chantal A A; Vonk Alieke G; Verschueren Ineke; Van Der Meer Jos W M; Kullberg Bart Jan
The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
The Journal of infectious diseases 2002;185(10):1483-9.
2002: Netea Mihai G; Kullberg Bart Jan; Galama Jochem M D; Stalenhoef Anton F H; Dinarello Charles A; Van der Meer Jos W M
Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.
European journal of immunology 2002;32(4):1188-95.
2002: van Crevel Reinout; Ottenhoff Tom H M; van der Meer Jos W M
Innate immunity to Mycobacterium tuberculosis.
Clinical microbiology reviews 2002;15(2):294-309.
2002: Netea Mihai G; Stuyt Rogier J L; Kim Soo-Hyun; Van der Meer Jos W M; Kullberg Bart Jan; Dinarello Charles A
The role of endogenous interleukin (IL)-18, IL-12, IL-1beta, and tumor necrosis factor-alpha in the production of interferon-gamma induced by Candida albicans in human whole-blood cultures.
The Journal of infectious diseases 2002;185(7):963-70.
2002: Karyadi Elvina; West Clive E; Schultink Werner; Nelwan Ronald H H; Gross Rainer; Amin Zulkifli; Dolmans Wil M V; Schlebusch Harald; van der Meer Jos W M
A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status.
The American journal of clinical nutrition 2002;75(4):720-7.
2002: van Gorp Eric C M; Suharti Catharina; Mairuhu Albert T A; Dolmans Wil M V; van Der Ven Johanna; Demacker Pierre N M; van Der Meer Jos W M
Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(8):1150-3.
2002: van der Werf Sieberen P; de Vree Berna; van Der Meer Jos W M; Bleijenberg Gijs
The relations among body consciousness, somatic symptom report, and information processing speed in chronic fatigue syndrome.
Neuropsychiatry, neuropsychology, and behavioral neurology 2002;15(1):2-9.
2002: Netea Mihai G; van Deuren Marcel; Kullberg Bart Jan; Cavaillon Jean-Marc; Van der Meer Jos W M
Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?
Trends in immunology 2002;23(3):135-9.
2002: van Crevel Reinout; Karyadi Elvina; Netea Mihai G; Verhoef Hans; Nelwan Ronald H H; West Clive E; van der Meer Jos W M
Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation.
The Journal of clinical endocrinology and metabolism 2002;87(2):758-63.
2002: Suharti Catharina; van Gorp Eric C M; Setiati Tatty E; Dolmans Wil M V; Djokomoeljanto Robert J; Hack C Erik; ten Cate Hugo; van der Meer Jos W M
The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.
Thrombosis and haemostasis 2002;87(1):42-6.
2001: Drenth J P; van der Meer J W
Hereditary periodic fever.
The New England journal of medicine 2001;345(24):1748-57.
2001: van Crevel R; Nelwan R H; de Lenne W; Veeraragu Y; van der Zanden A G; Amin Z; van der Meer J W; van Soolingen D
Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment.
Emerging infectious diseases 2001;7(5):880-3.
2001: Netea M G; Kullberg B J; Joosten L A; Sprong T; Verschueren I; Boerman O C; Amiot F; van den Berg W B; Van der Meer J W
Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways.
European journal of immunology 2001;31(9):2529-38.
2001: Simon A; Cuisset L; Vincent M F; van Der Velde-Visser S D; Delpech M; van Der Meer J W; Drenth J P
Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool.
Annals of internal medicine 2001;135(5):338-43.
2001: Drenth J P; Vonk A G; Simon A; Powell R; van der Meer J W
Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1221-6.
2001: van der Meer J W; Cools B M
[Diagnostic image (51). Right-sided endocarditis in a heroin addict ]
Nederlands tijdschrift voor geneeskunde 2001;145(33):1590.
2001: Sprong T; Stikkelbroeck N; van der Ley P; Steeghs L; van Alphen L; Klein N; Netea M G; van der Meer J W; van Deuren M
Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response.
Journal of leukocyte biology 2001;70(2):283-8.
2001: Natsch S; Steeghs M H; Hekster Y A; Meis J F; van der Meer J W; Kullberg B J
Use of fluconazole in daily practice: still room for improvement.
The Journal of antimicrobial chemotherapy 2001;48(2):303-10.
2001: Stuyt R J; Netea M G; Kim S H; Novick D; Rubinstein M; Kullberg B J; Van der Meer J W; Dinarello C A
Differential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens.
Infection and immunity 2001;69(8):5025-30.
2001: Stearne L E; Gyssens I C; Goessens W H; Mouton J W; Oyen W J; van der Meer J W; Verbrugh H A
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Antimicrobial agents and chemotherapy 2001;45(5):1394-401.
2001: Cuisset L; Drenth J P; Simon A; Vincent M F; van der Velde Visser S; van der Meer J W; Grateau G; Delpech M;
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.
European journal of human genetics : EJHG 2001;9(4):260-6.
2001: van Crevel R; de Lange W C; Vanderpuye N A; van Soolingen D; Hoogkamp-Korstanje J A; van Deuren K M; Kullberg B J; van Herwaarden C; van der Meer J W
The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis.
Infection 2001;29(2):59-63.
2001: Prins J B; Bleijenberg G; Bazelmans E; Elving L D; de Boo T M; Severens J L; van der Wilt G J; Spinhoven P; van der Meer J W
Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.
Lancet 2001;357(9259):841-7.
2001: Simon A; Dodé C; van der Meer J W; Drenth J P
Familial periodic fever and amyloidosis due to a new mutation in the TNFRSF1A gene.
The American journal of medicine 2001;110(4):313-6.
2001: De Vries M; Soetekouw P M; Van Der Meer J W; Bleijenberg G
Natural course of symptoms in Cambodia veterans: a follow-up study.
Psychological medicine 2001;31(2):331-8.
2001: Simon A; Drenth J P; van der Meer J W
[From gene to disease; tumor necrosis factor receptor and a syndrome of familial periodic fever]
Nederlands tijdschrift voor geneeskunde 2001;145(2):77-8.
2001: Bazelmans E; Bleijenberg G; Van Der Meer J W; Folgering H
Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity.
Psychological medicine 2001;31(1):107-14.
2001: van der Meer J W; Fibbe W E
[Diagnostic image (19). Ecthyma gangraenosum]
Nederlands tijdschrift voor geneeskunde 2001;145(1):24.
2001: Rennen H J; Boerman O C; Oyen W J; van der Meer J W; Corstens F H
Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(1):117-23.
2001: Peeters A C; Netea M G; Janssen M C; Kullberg B J; Van der Meer J W; Thien T
Pro-inflammatory cytokines in patients with essential hypertension.
European journal of clinical investigation 2001;31(1):31-6.
2001: Klasen I S; Göertz J H; van de Wiel G A; Weemaes C M; van der Meer J W; Drenth J P
Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome.
Clinical and diagnostic laboratory immunology 2001;8(1):58-61.
2001: van der Meer J W; Gyssens I C
Quality of antimicrobial drug prescription in hospital.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7 Suppl 6():12-5.
2000: van Crevel R; Vonk A G; Netea M G; Kullberg B J; van der Meer J W
Modulation of LPS-, PHA- and M. tuberculosis-mediated cytokine production by pentoxifylline and thalidomide.
European cytokine network 2000;11(4):574-9.
2000: Karyadi E; Schultink W; Nelwan R H; Gross R; Amin Z; Dolmans W M; van der Meer J W; Hautvast J G; West C E
Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia.
The Journal of nutrition 2000;130(12):2953-8.
2000: Vreugdenhil G R; Wijnands P G; Netea M G; van der Meer J W; Melchers W J; Galama J M
Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes.
Cytokine 2000;12(12):1793-6.
2000: Joosten L A; van De Loo F A; Lubberts E; Helsen M M; Netea M G; van Der Meer J W; Dinarello C A; van Den Berg W B
An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(11):6553-8.
2000: van der Meer J W
[Diagnostic image (12). Ramsay Hunt syndrome]
Nederlands tijdschrift voor geneeskunde 2000;144(47):2257.
2000: Netea M G; Kullberg B J; Van der Meer J W
Circulating cytokines as mediators of fever.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31 Suppl 5():S178-84.
2000: Netea M G; Kullberg B J; Verschueren I; Van Der Meer J W
Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta.
European journal of immunology 2000;30(10):3057-60.
2000: van der Meer J W; Fibbe W E
[Diagnostic image (6) (Pustulous skin lesions)]
Nederlands tijdschrift voor geneeskunde 2000;144(41):1953.
2000: van der Meer J W
[Diagnostic image (2). (Gas gangrene of diabetic foot)]
Nederlands tijdschrift voor geneeskunde 2000;144(37):1779.
2000: de Bont N; Netea M G; Demacker P N; Kullberg B J; van der Meer J W; Stalenhoef A F
Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae.
European journal of clinical investigation 2000;30(9):818-22.
2000: van der Meer J W
Future needs--clinical services for infectious diseases.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(8):426-7.
2000: van der Werf S P; Prins J B; Jongen P J; van der Meer J W; Bleijenberg G
Abnormal neuropsychological findings are not necessarily a sign of cerebral impairment: a matched comparison between chronic fatigue syndrome and multiple sclerosis.
Neuropsychiatry, neuropsychology, and behavioral neurology 2000;13(3):199-203.
2000: Soetekouw P M; de Vries M; van Bergen L; Galama J M; Keyser A; Bleijenberg G; van der Meer J W
Somatic hypotheses of war syndromes.
European journal of clinical investigation 2000;30(7):630-41.
2000: Soetekouw P M; Wevers R A; Vreken P; Elving L D; Janssen A J; van der Veen Y; Bleijenberg G; van der Meer J W
Normal carnitine levels in patients with chronic fatigue syndrome.
The Netherlands journal of medicine 2000;57(1):20-4.
2000: de Vries M; Soetekouw P M; Van Der Meer J W; Bleijenberg G
Fatigue in Cambodia veterans.
QJM : monthly journal of the Association of Physicians 2000;93(5):283-9.
2000: Dams E T; Nijhof M W; Boerman O C; Laverman P; Storm G; Buma P; Lemmens J A; van der Meer J W; Corstens F H; Oyen W J
Scintigraphic evaluation of experimental chronic osteomyelitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):896-902.
2000: Natsch S; Kullberg B J; Meis J F; van der Meer J W
Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department.
Archives of internal medicine 2000;160(9):1317-20.
2000: Oyen W J; Boerman O C; Brouwers F M; Barrett J A; Verheugt F W; Ruiter D J; Corstens F H; van der Meer J W
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444.
European journal of nuclear medicine 2000;27(4):392-9.
2000: Drenth J P; Waterham H R; Kuis W; Houten S M; Frenkel J; Wanders R J; Poll-The B T; van der Meer J W
[Identification of the gene for hyper-IgD syndrome: a model of modern genetics]
Nederlands tijdschrift voor geneeskunde 2000;144(17):782-5.
2000: Dams E T; Oyen W J; Boerman O C; Storm G; Laverman P; Kok P J; Buijs W C; Bakker H; van der Meer J W; Corstens F H
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):622-30.
2000: van Crevel R; Karyadi E; Preyers F; Leenders M; Kullberg B J; Nelwan R H; van der Meer J W
Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities.
The Journal of infectious diseases 2000;181(3):1194-7.
2000: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; van der Meer J W; Corstens F H
Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(3):463-9.
2000: Dams E T; Laverman P; Oyen W J; Storm G; Scherphof G L; van Der Meer J W; Corstens F H; Boerman O C
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
The Journal of pharmacology and experimental therapeutics 2000;292(3):1071-9.
2000: Netea M G; Fantuzzi G; Kullberg B J; Stuyt R J; Pulido E J; McIntyre R C; Joosten L A; Van der Meer J W; Dinarello C A
Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(5):2644-9.
2000: Netea M G; Selzman C H; Kullberg B J; Galama J M; Weinberg A; Stalenhoef A F; Van der Meer J W; Dinarello C A
Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells.
European journal of immunology 2000;30(2):541-9.
2000: van Deuren M; Brandtzaeg P; van der Meer J W
Update on meningococcal disease with emphasis on pathogenesis and clinical management.
Clinical microbiology reviews 2000;13(1):144-66, table of contents.
1999: Soetekouw P M; Lenders J W; Bleijenberg G; Thien T; van der Meer J W
Autonomic function in patients with chronic fatigue syndrome.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1999;9(6):334-40.
1999: de Vries M; Soetekouw P M; van Bergen L F; van der Meer J W; Bleijenberg G
[Somatic and psychological symptoms in soldiers after military clashes and peace-keeping missions]
Nederlands tijdschrift voor geneeskunde 1999;143(51):2557-62.
1999: Bazelmans E; Vercoulen J H; Swanink C M; Fennis J F; Galama J M; van Weel C; van der Meer J W; Bleijenberg G
Chronic Fatigue Syndrome and Primary Fibromyalgia Syndrome as recognized by GPs.
Family practice 1999;16(6):602-4.
1999: Kullberg B J; Netea M G; Vonk A G; van der Meer J W
Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice.
FEMS immunology and medical microbiology 1999;26(3-4):299-307.
1999: Gyssens I C; Kullberg B J; van der Meer J W
[Clinical results and costs due to improved antibiotics policies]
Nederlands tijdschrift voor geneeskunde 1999;143(47):2361-4.
1999: Soetekouw P M; De Vries M; Preijers F W; Van Crevel R; Bleijenberg G; Van Der Meer J W
Persistent symptoms in former UNTAC soldiers are not associated with shifted cytokine balance.
European journal of clinical investigation 1999;29(11):960-3.
1999: Vonk A G; Netea M G; van der Meer J W; Kullberg B J
Modulation of the pro- and antiinflammatory cytokines by amphotericin B.
The Journal of infectious diseases 1999;180(4):1408-11.
1999: de Bont N; Geijtenbeek T B; Netea M G; Smilde T J; Demacker P N; Figdor C G; Van Der Meer J W; Stalenhoef A F
Integrin mediated adhesion of mononuclear cells from patients with familial hypercholesterolemia.
European journal of clinical investigation 1999;29(9):749-57.
1999: Corstens F H; van der Meer J W
Nuclear medicine's role in infection and inflammation.
Lancet 1999;354(9180):765-70.
1999: Netea M G; van Tits L J; Curfs J H; Amiot F; Meis J F; van der Meer J W; Kullberg B J
Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(3):1498-505.
1999: van Gorp E C; Suharti C; ten Cate H; Dolmans W M; van der Meer J W; ten Cate J W; Brandjes D P
Review: infectious diseases and coagulation disorders.
The Journal of infectious diseases 1999;180(1):176-86.
1999: van Kasteren M; Kullberg B J; van der Meer J W
[Management and choice of antibiotics for patients with an allergy to penicillin]
Nederlands tijdschrift voor geneeskunde 1999;143(23):1239-40.
1999: Drenth J P; Cuisset L; Grateau G; Vasseur C; van de Velde-Visser S D; de Jong J G; Beckmann J S; van der Meer J W; Delpech M
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.
Nature genetics 1999;22(2):178-81.
1999: Netea M G; Curfs J H; Demacker P N; Meis J F; Van der Meer J W; Kullberg B J
Infusion of lipoproteins into volunteers enhances the growth of Candida albicans.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(5):1148-51.
1999: van Deuren M; Neeleman C; van der Meer J W
[The young child with fever of unknown origin: diagnosis and management]
Nederlands tijdschrift voor geneeskunde 1999;143(20):1065; author reply 1065-6.
1999: Kruimel J W; Pesman G J; Sweep C G; van der Vliet J A; Liem T; Jansen J B; van der Meer J W; Naber A H
Depression of plasma levels of cytokines and ex-vivo cytokine production in relation to the activity of the pituitary-adrenal axis, in patients undergoing major vascular surgery.
Cytokine 1999;11(5):382-8.
1999: Dams E T; Reijnen M M; Oyen W J; Boerman O C; Laverman P; Storm G; van der Meer J W; Corstens F H; van Goor H
Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG.
Annals of surgery 1999;229(4):551-7.
1999: Netea M G; Kullberg B J; Boerman O C; Verschueren I; Dinarello C A; Van der Meer J W
Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4876-81.
1999: de Bont N; Netea M G; Demacker P N; Verschueren I; Kullberg B J; van Dijk K W; van der Meer J W; Stalenhoef A F
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection.
Journal of lipid research 1999;40(4):680-5.
1999: van Kasteren M E; Stobberingh E E; Janknegt R; Wijnands W J; van der Meer J W
[Optimizing the antibiotics policy in the Netherlands. IV. SWAB- guidelines for antimicrobial therapy of adults with sepsis in hospitals. Foundation Antibiotics Policy Work Group]
Nederlands tijdschrift voor geneeskunde 1999;143(12):611-7.
1999: Netea M G; Kullberg B J; Blok W L; Van der Meer J W
Immunomodulation by n-3 polyunsaturated fatty acids.
Immunology today 1999;20(2):103.
1999: du Buf-Vereijken P W; van der Ven A J; Meis J F; Lemmens J A; van der Meer J W
Swelling of hand and forearm caused by Mycobacterium bovis.
The Netherlands journal of medicine 1999;54(2):70-2.
1999: van Crevel R; van der Ven-Jongekrijg J; Netea M G; de Lange W; Kullberg B J; van der Meer J W
Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis.
Journal of immunological methods 1999;222(1-2):145-53.
1999: Laverman P; Dams E T; Oyen W J; Storm G; Koenders E B; Prevost R; van der Meer J W; Corstens F H; Boerman O C
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):192-7.
1998: Dams E T; Oyen W J; Boerman O C; Storm G; Laverman P; Koenders E B; van der Meer J W; Corstens F H
Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2172-8.
1998: Vercoulen J H; Swanink C M; Galama J M; Fennis J F; Jongen P J; Hommes O R; van der Meer J W; Bleijenberg G
The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model.
Journal of psychosomatic research 1998;45(6):507-17.
1998: van Kasteren M E; Wijnands W J; Stobberingh E E; Janknegt R; van der Meer J W
[Optimizing of antibiotics policy in the Netherlands. III. SWAB guidelines for antimicrobial therapy in adults hospitalized with bronchitis. Foundation Antibiotics Policy Work Group]
Nederlands tijdschrift voor geneeskunde 1998;142(46):2512-5.
1998: van Deuren M; Twickler T B; de Waal Malefyt M C; Van Beem H; van der Ven-Jongekrijg J; Verschueren C M; van der Meer J W
Elective orthopedic surgery, a model for the study of cytokine activation and regulation.
Cytokine 1998;10(11):897-903.
1998: Rovers C; Netea M G; de Bont N; Demacker P N; Jacobs C; Kullberg B J; Van der Meer J W; Stalenhoef A F
LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia.
Atherosclerosis 1998;141(1):99-105.
1998: Netea M G; Demacker P N; Kullberg B J; Boerman O C; Verschueren I; Stalenhoef A F; Van Der Meer J W
Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.
Immunology 1998;95(3):466-72.
1998: Natsch S; Kullberg B J; van der Meer J W; Meis J F
Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(10):681-4.
1998: Vonk A G; Netea M G; Denecker N E; Verschueren I C; van der Meer J W; Kullberg B J
Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B.
The Journal of antimicrobial chemotherapy 1998;42(4):469-74.
1998: Netea M G; Demacker P N; Kullberg B J; Jacobs L E; Verver-Jansen T J; Boerman O C; Stalenhoef A F; Van der Meer J W
Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur.
Cytokine 1998;10(10):766-72.
1998: van der Meer J W; Vogels M T; Netea M G; Kullberg B J
Proinflammatory cytokines and treatment of disease.
Annals of the New York Academy of Sciences 1998;856():243-51.
1998: Buijs W C; Oyen W J; Dams E T; Boerman O C; Siegel J A; Claessens R A; van der Meer J W; Corstens F H
Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
Nuclear medicine communications 1998;19(8):743-51.
1998: Peeters A C; Netea M G; Kullberg B J; Thien T; van der Meer J W
The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production.
Immunology 1998;94(3):376-9.
1998: Netea M G; Kullberg B J; van der Meer J W
Lipopolysaccharide-induced production of tumour necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD14-dependent and CD14-independent pathways.
Immunology 1998;94(3):340-4.
1998: de Bont N; Netea M G; Rovers C; Smilde T; Demacker P N; van der Meer J W; Stalenhoef A F
LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors.
Atherosclerosis 1998;139(1):147-52.
1998: Natsch S; van Kasteren M E; Kullberg B J; van der Meer J W
Guidelines for the prevention of antimicrobial resistance in hospitals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(6):1482-3.
1998: Swanink C M; Stolk-Engelaar V M; van der Meer J W; Vercoulen J H; Bleijenberg G; Fennis J F; Galama J M; Hoogkamp-Korstanje J A
Yersinia enterocolitica and the chronic fatigue syndrome.
The Journal of infection 1998;36(3):269-72.
1998: van Deuren M; Netea M G; Hijmans A; Demacker P N; Neeleman C; Sauerwein R W; Bartelink A K; van der Meer J W
Posttranscriptional down-regulation of tumor necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections.
The Journal of infectious diseases 1998;177(5):1401-5.
1998: van der Laken C J; Boerman O C; Oyen W J; Laverman P; van de Ven M T; Corstens F H; van der Meer J W
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
The Journal of infectious diseases 1998;177(5):1398-401.
1998: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; van der Meer J W; Corstens F H
Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
European journal of nuclear medicine 1998;25(5):535-46.
1998: Netea M G; de Bont N; Demacker P N; Kullberg B J; Jacobs L E; Verver-Jansen T J; Stalenhoef A F; Van der Meer J W
Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells.
Infection and immunity 1998;66(5):2365-7.
1998: Vercoulen J H; Bazelmans E; Swanink C M; Galama J M; Fennis J F; van der Meer J W; Bleijenberg G
Evaluating neuropsychological impairment in chronic fatigue syndrome.
Journal of clinical and experimental neuropsychology 1998;20(2):144-56.
1998: van Kasteren M E; Wijnands W J; Stobberingh E E; Janknegt R; van der Meer J W
[Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation]
Nederlands tijdschrift voor geneeskunde 1998;142(17):952-6.
1998: van Kasteren M E; Wijnands W J; Stobberingh E E; Janknegt R; Verbrugh H A; van der Meer J W
[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)]
Nederlands tijdschrift voor geneeskunde 1998;142(17):949-51.
1998: de Sévaux R G; Kullberg B J; Verweij P E; van de Nes J A; Meis J F; van der Meer J W
Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(4):996-7.
1998: van Deuren M; Frieling J T; van der Ven-Jongekrijg J; Neeleman C; Russel F G; van Lier H J; Bartelink A K; van der Meer J W
Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(4):918-23.
1998: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; van der Meer J W; Corstens F H
Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study.
European journal of nuclear medicine 1998;25(4):347-52.
1998: Van Deuren M; Neeleman C; Van 't Hek L G; Van der Meer J W
A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course.
Intensive care medicine 1998;24(2):157-61.
1998: Natsch S; Hekster Y A; de Jong R; Heerdink E R; Herings R M; van der Meer J W
Application of the ATC/DDD methodology to monitor antibiotic drug use.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(1):20-4.
1998: van Deuren M; Neeleman C; Assmann K J; Wetzels J F; van der Meer J W
Rhabdomyolysis during the subacute stage of meningococcal sepsis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(1):214-5.
1998: Dams E T; Oyen W J; Boerman O C; Claessens R A; Wymenga A B; van der Meer J W; Corstens F H
Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):119-24.
1998: Kullberg B J; Netea M G; Curfs J H; Keuter M; Meis J F; van der Meer J W
Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice.
The Journal of infectious diseases 1998;177(1):175-81.
1997: van Kasteren M E; Natsch S; van der Meer J W
[Current antimicrobial drugs]
Nederlands tijdschrift voor geneeskunde 1997;141(49):2392-6.
1997: Gyssens I C; Blok W L; van den Broek P J; Hekster Y A; van der Meer J W
Implementation of an educational program and an antibiotic order form to optimize quality of antimicrobial drug use in a department of internal medicine.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(12):904-12.
1997: Blok W L; Deslypere J P; Demacker P N; van der Ven-Jongekrijg J; Hectors M P; van der Meer J W; Katan M B
Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year.
European journal of clinical investigation 1997;27(12):1003-8.
1997: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Chizzonite R; Corstens F H; van der Meer J W
Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.
The Journal of clinical investigation 1997;100(12):2970-6.
1997: Vercoulen J H; Bazelmans E; Swanink C M; Fennis J F; Galama J M; Jongen P J; Hommes O; Van der Meer J W; Bleijenberg G
Physical activity in chronic fatigue syndrome: assessment and its role in fatigue.
Journal of psychiatric research 1997;31(6):661-73.
1997: Oyen W J; Boerman O C; Dams E T; Storm G; van Bloois L; Koenders E B; van Haelst U J; van der Meer J W; Corstens F H
Scintigraphic evaluation of experimental colitis in rabbits.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1596-600.
1997: Bazelmans E; Bleijenberg G; Vercoulen J H; van der Meer J W; Folgering H
The chronic fatigue syndrome and hyperventilation.
Journal of psychosomatic research 1997;43(4):371-7.
1997: Denecker N E; Kullberg B J; Drenth J P; Raemaekers J M; Van der Meer J W
Regulation of the production of pro-inflammatory cytokines and antagonists during chemotherapy-induced neutropenia in patients with haematological malignancies.
Cytokine 1997;9(9):702-10.
1997: Bazelmans E; Vercoulen J H; Galama J M; van Weel C; van der Meer J W; Bleijenberg G
[Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in The Netherlands]
Nederlands tijdschrift voor geneeskunde 1997;141(31):1520-3.
1997: Bleeker M W; Netea M G; Kullberg B J; Van der Ven-Jongekrijg J; Van der Meer J W
The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers.
Immunology 1997;91(4):548-52.
1997: Nijhof M W; Oyen W J; van Kampen A; Claessens R A; van der Meer J W; Corstens F H
Hip and knee arthroplasty infection. In-111-IgG scintigraphy in 102 cases.
Acta orthopaedica Scandinavica 1997;68(4):332-6.
1997: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Edwards D S; Barrett J A; van der Meer J W; Corstens F H
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1310-5.
1997: Nijhof M W; Oyen W J; van Kampen A; Claessens R A; van der Meer J W; Corstens F H
Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1300-5.
1997: van Deuren M; van der Ven-Jongekrijg J; Vannier E; van Dalen R; Pesman G; Bartelink A K; Dinarello C A; van der Meer J W
The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.
Blood 1997;90(3):1101-8.
1997: Netea M G; Demacker P N; de Bont N; Boerman O C; Stalenhoef A F; van der Meer J W; Kullberg B J
Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice.
Infection and immunity 1997;65(7):2663-7.
1997: Boerman O C; Oyen W J; Storm G; Corvo M L; van Bloois L; van der Meer J W; Corstens F H
Technetium-99m labelled liposomes to image experimental arthritis.
Annals of the rheumatic diseases 1997;56(6):369-73.
1997: Kranenborg M H; Oyen W J; Corstens F H; Oosterwijk E; van der Meer J W; Boerman O C
Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):901-6.
1997: Sauerwein R W; Mulder J A; Mulder L; Lowe B; Peshu N; Demacker P N; van der Meer J W; Marsh K
Inflammatory mediators in children with protein-energy malnutrition.
The American journal of clinical nutrition 1997;65(5):1534-9.
1997: Perenboom R M; Sauerwein R W; Beckers P; van Schijndel A C; van Steenwijk R P; Borleffs J C; van Leusen R; van der Meer J W
Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV-seropositive patients with Pneumocystis carinii pneumonia.
European journal of clinical investigation 1997;27(4):333-9.
1997: Netea M G; Hancu N; Blok W L; Grigorescu-Sido P; Popa L; Popa V; van der Meer J W
Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
Cytokine 1997;9(4):284-7.
1997: Boerman O C; Oyen W J; van Bloois L; Koenders E B; van der Meer J W; Corstens F H; Storm G
Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):489-93.
1997: van de Ven M J; Lenders J W; Baas A A; Holdrinet A C; van der Meer J W
[Idiopathic CD4(+)-T-lymphocytopenia]
Nederlands tijdschrift voor geneeskunde 1997;141(6):298-301.
1997: Netea M G; Kullberg B J; Blok W L; Netea R T; van der Meer J W
The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice.
Blood 1997;89(2):577-82.
1996: Gyssens I C; Geerligs I E; Dony J M; van der Vliet J A; van Kampen A; van den Broek P J; Hekster Y A; van der Meer J W
Optimising antimicrobial drug use in surgery: an intervention study in a Dutch university hospital.
The Journal of antimicrobial chemotherapy 1996;38(6):1001-12.
1996: Perenboom R M; Beckers P; Van Der Meer J W; Van Schijndel A C; Oyen W J; Corstens F H; Sauerwein R W
Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats.
Journal of leukocyte biology 1996;60(6):710-5.
1996: Blok W L; de Bruijn M F; Leenen P J; Eling W M; van Rooijen N; Stanley E R; Buurman W A; van der Meer J W
Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(12):5569-73.
1996: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Claessens R A; van der Meer J W; Corstens F H
Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection.
European journal of nuclear medicine 1996;23(11):1531-5.
1996: Jansen M J; Hendriks T; Huyben C M; Tax W J; van der Meer J W; Goris R J
Increasing cytotoxic activity and production of reactive oxygen and nitrogen intermediates by peritoneal macrophages during the development of multiple organ dysfunction syndrome in mice.
Scandinavian journal of immunology 1996;44(4):361-8.
1996: Netea M G; Drenth J P; De Bont N; Hijmans A; Keuter M; Dharmana E; Demacker P N; van der Meer J W
A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of MRNA for TNF-alpha and IL-1 beta in whole blood cultures: its application in typhoid fever and exentric exercise.
Cytokine 1996;8(9):739-44.
1996: Oyen W J; Boerman O C; Storm G; van Bloois L; Koenders E B; Crommelin D J; van der Meer J W; Corstens F H
Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy?
Nuclear medicine communications 1996;17(9):742-8.
1996: Gyssens I C; Geerligs I E; Nannini-Bergman M G; Knape J T; Hekster Y A; van der Meer J W
Optimizing the timing of antimicrobial prophylaxis in surgery: an intervention study.
The Journal of antimicrobial chemotherapy 1996;38(2):301-8.
1996: Blok W L; Gyssens I C; Hekster Y A; Koopmans P P; van der Meer J W
Feasibility of an antibiotic order form. First experience in the department of internal medicine of a university hospital.
Pharmacy world & science : PWS 1996;18(4):137-41.
1996: Oyen W J; Boerman O C; Storm G; van Bloois L; Koenders E B; Claessens R A; Perenboom R M; Crommelin D J; van der Meer J W; Corstens F H
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(8):1392-7.
1996: Vercoulen J H; Hommes O R; Swanink C M; Jongen P J; Fennis J F; Galama J M; van der Meer J W; Bleijenberg G
The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects.
Archives of neurology 1996;53(7):642-9.
1996: van der Ven A J; Schoondermark-van de Ven E M; Camps W; Melchers W J; Koopmans P P; van der Meer J W; Galama J M
Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy.
The Journal of antimicrobial chemotherapy 1996;38(1):75-80.
1996: Oyen W J; Boerman O C; Subramanian R; Koenders E B; Claessens R A; van der Meer J W; Corstens F H
Biodistribution of 111In-labelled IgG and IgM in experimental infection.
Nuclear medicine communications 1996;17(7):616-20.
1996: Drenth J P; Göertz J; Daha M R; van der Meer J W
Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.
Immunology 1996;88(3):355-62.
1996: Jansen M J; Hendriks T; Vogels M T; van der Meer J W; Goris R J
Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome.
Critical care medicine 1996;24(7):1196-202.
1996: Oyen W J; Boerman O C; van der Laken C J; van der Meer J W; Corstens F H
Macrophage targeting in experimental arthritis.
European journal of nuclear medicine 1996;23(6):727-9.
1996: Blok W L; Katan M B; van der Meer J W
Modulation of inflammation and cytokine production by dietary (n-3) fatty acids.
The Journal of nutrition 1996;126(6):1515-33.
1996: Vercoulen J H; Swanink C M; Fennis J F; Galama J M; van der Meer J W; Bleijenberg G
Prognosis in chronic fatigue syndrome: a prospective study on the natural course.
Journal of neurology, neurosurgery, and psychiatry 1996;60(5):489-94.
1996: Oyen W J; Boerman O C; van der Laken C J; Claessens R A; van der Meer J W; Corstens F H
The uptake mechanisms of inflammation- and infection-localizing agents.
European journal of nuclear medicine 1996;23(4):459-65.
1996: Claessens R A; Boerman O C; Koenders E B; Oyen W J; van der Meer J W; Corstens F H
Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.
European journal of nuclear medicine 1996;23(4):414-21.
1996: Vercoulen J H; Swanink C M; Zitman F G; Vreden S G; Hoofs M P; Fennis J F; Galama J M; van der Meer J W; Bleijenberg G
Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
Lancet 1996;347(9005):858-61.
1996: Netea M G; Demacker P N; Kullberg B J; Boerman O C; Verschueren I; Stalenhoef A F; van der Meer J W
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.
The Journal of clinical investigation 1996;97(6):1366-72.
1996: Perenboom R M; van Schijndel A C; Beckers P; Sauerwein R; Van Hamersvelt H W; Festen J; Gallati H; van der Meer J W
Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV-seronegative patients with Pneumocystis carinii pneumonia.
European journal of clinical investigation 1996;26(2):159-66.
1996: Swanink C M; Vercoulen J H; Galama J M; Roos M T; Meyaard L; van der Ven-Jongekrijg J; de Nijs R; Bleijenberg G; Fennis J F; Miedema F; van der Meer J W
Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome.
The Journal of infectious diseases 1996;173(2):460-3.
1996: van der Meer J W; Koopmans P P; Lutterman J A
Antibiotic therapy in diabetic foot infection.
Diabetic medicine : a journal of the British Diabetic Association 1996;13 Suppl 1():S48-51.
1995: Drenth J P; Van Uum S H; Van Deuren M; Pesman G J; Van der Ven-Jongekrijg J; Van der Meer J W
Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.
Journal of applied physiology (Bethesda, Md. : 1985) 1995;79(5):1497-503.
1995: van der Laken C J; Boerman O C; Oyen W J; van de Ven M T; Claessens R A; van der Meer J W; Corstens F H
Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model.
European journal of nuclear medicine 1995;22(11):1249-55.
1995: Perenboom R M; Oyen W J; van Schijndel A C; Beckers P; Corstens F H; van der Meer J W
Serial indium-111-labelled IgG biodistribution in rat Pneumocystis carinii pneumonia: a tool to monitor the course and severity of the infection.
European journal of nuclear medicine 1995;22(10):1129-32.
1995: de Kleijn E M; Oyen W J; Claessens R A; Corstens F H; van der Meer J W
Utility of scintigraphic methods in patients with fever of unknown origin.
Archives of internal medicine 1995;155(18):1989-94.
1995: Swanink C M; Vercoulen J H; Bazelmans E; Fennis J F; Bleijenberg G; van der Meer J W; Galama J M
Viral antibodies in chronic fatigue syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):708-9.
1995: Boerman O C; Storm G; Oyen W J; van Bloois L; van der Meer J W; Claessens R A; Crommelin D J; Corstens F H
Sterically stabilized liposomes labeled with indium-111 to image focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(9):1639-44.
1995: Drenth J P; Denecker N E; Prieur A M; Van der Meer J W
[Hyperimmunoglobulin D syndrome]
Presse médicale (Paris, France : 1983) 1995;24(26):1211-3.
1995: Drenth J P; Powell R J; Brown N S; Van der Meer J W
Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome.
European journal of clinical investigation 1995;25(9):683-6.
1995: van Deuren M; van der Ven-Jongekrijg J; Bartelink A K; van Dalen R; Sauerwein R W; van der Meer J W
Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.
The Journal of infectious diseases 1995;172(2):433-9.
1995: de Kleijn E M; van der Meer J W
Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital.
The Netherlands journal of medicine 1995;47(2):54-60.
1995: Vogels M T; Eling W M; Otten A; van der Meer J W
Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor.
Antimicrobial agents and chemotherapy 1995;39(8):1744-7.
1995: Keuter M; Dharmana E; Kullberg B J; Schalkwijk C; Gasem M H; Seuren L; Djokomoeljanto R; Dolmans W M; van den Bosch H; van der Meer J W
Phospholipase A2 is a circulating mediator in typhoid fever.
The Journal of infectious diseases 1995;172(1):305-8.
1995: Drenth J P; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk C G; van der Meer J W
Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
Blood 1995;85(12):3586-93.
1995: Drenth J P; de Kleijn E H; de Mulder P H; van der Meer J W
Metastatic breast cancer presenting as fever, rash, and arthritis.
Cancer 1995;75(7):1608-11.
1995: Janknegt R; Stobberingh E E; Wijnands W J; van der Meer J W
[Antibiotic policy in Dutch hospitals]
Nederlands tijdschrift voor geneeskunde 1995;139(10):485-7.
1995: Claessens R A; Koenders E B; Boerman O C; Oyen W J; Borm G F; van der Meer J W; Corstens F H
Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci.
European journal of nuclear medicine 1995;22(3):212-9.
1995: Netea M G; Blok W L; Kullberg B J; Bemelmans M; Vogels M T; Buurman W A; van der Meer J W
Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.
The Journal of infectious diseases 1995;171(2):393-9.
1995: Frieling J T; van Deuren M; Wijdenes J; van der Meer J W; Clement C; van der Linden C J; Sauerwein R W
Circulating interleukin-6 receptor in patients with sepsis syndrome.
The Journal of infectious diseases 1995;171(2):469-72.
1994: Vogels M T; Mensink E J; Ye K; Boerman O C; Verschueren C M; Dinarello C A; van der Meer J W
Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(12):5772-80.
1994: Drenth J P; Mariman E C; Van der Velde-Visser S D; Ropers H H; Van der Meer J W
Location of the gene causing hyperimmunoglobulinemia D and periodic fever syndrome differs from that for familial Mediterranean fever. International Hyper-IgD Study Group.
Human genetics 1994;94(6):616-20.
1994: Gyssens I C; Kullberg B J; van der Meer J W
[Belt and suspenders. Medical jargon in The Netherlands and Flanders]
Nederlands tijdschrift voor geneeskunde 1994;138(52):2625-6.
1994: Vercoulen J H; Swanink C M; Fennis J F; Galama J M; van der Meer J W; Bleijenberg G
Dimensional assessment of chronic fatigue syndrome.
Journal of psychosomatic research 1994;38(5):383-92.
1994: Keuter M; Dharmana E; Gasem M H; van der Ven-Jongekrijg J; Djokomoeljanto R; Dolmans W M; Demacker P; Sauerwein R; Gallati H; van der Meer J W
Patterns of proinflammatory cytokines and inhibitors during typhoid fever.
The Journal of infectious diseases 1994;169(6):1306-11.
1994: Drenth J P; Haagsma C J; van der Meer J W
Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group.
Medicine 1994;73(3):133-44.
1994: Vogels M T; Hermsen C C; Huys H L; Eling W M; van der Meer J W
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice.
Infection and immunity 1994;62(5):2065-70.
1994: Oyen W J; Boerman O C; Claessens R A; van der Meer J W; Corstens F H
Is somatostatin receptor scintigraphy suited to detection of acute infectious disease?
Nuclear medicine communications 1994;15(4):289-93.
1994: Drenth J P; Boom B W; Toonstra J; Van der Meer J W
Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group.
Archives of dermatology 1994;130(1):59-65.
1994: van Deuren M; van der Ven-Jongekrijg J; Demacker P N; Bartelink A K; van Dalen R; Sauerwein R W; Gallati H; Vannice J L; van der Meer J W
Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
The Journal of infectious diseases 1994;169(1):157-61.
1994: van der Meer J W; Vogels M T; Kullberg B J
Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals.
Biotherapy (Dordrecht, Netherlands) 1994;7(3-4):161-7.
1994: Kullberg B J; van der Meer J W
Introduction: cytokines in the biotherapy of infectious diseases.
Biotherapy (Dordrecht, Netherlands) 1994;7(3-4):149-50.
1993: Roumen R M; Hendriks T; van der Ven-Jongekrijg J; Nieuwenhuijzen G A; Sauerwein R W; van der Meer J W; Goris R J
Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure.
Annals of surgery 1993;218(6):769-76.
1993: Vogels M T; Cantoni L; Carelli M; Sironi M; Ghezzi P; van der Meer J W
Role of acute-phase proteins in interleukin-1-induced nonspecific resistance to bacterial infections in mice.
Antimicrobial agents and chemotherapy 1993;37(12):2527-33.
1993: Oyen W J; Arntz I E; Claessens R M; Van der Meer J W; Corstens F H; Goris R J
Reflex sympathetic dystrophy of the hand: an excessive inflammatory response?
Pain 1993;55(2):151-7.
1993: van der Meer J W; Weening R S; Schellekens P T; van Munster I P; Nagengast F M
Colorectal cancer in patients with X-linked agammaglobulinaemia.
Lancet 1993;341(8858):1439-40.
1993: Vogels M T; Lindley I J; Curfs J H; Eling W M; van der Meer J W
Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice.
Antimicrobial agents and chemotherapy 1993;37(2):276-80.
1993: van der Meer J W; Vogels M; Curfs J H; Eling W M
Interleukin-1 as a possible agent for treatment of infection.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12 Suppl 1():S73-7.
1992: Vreden S G; Brenninkmeijer B J; van der Meer J W
Peritoneal tuberculosis in two young immigrants with fever of unknown origin.
The Netherlands journal of medicine 1992;41(5-6):218-21.
1992: van Deuren M; Dofferhoff A S; van der Meer J W
Cytokines and the response to infection.
The Journal of pathology 1992;168(4):349-56.
1992: Vogels M T; Sweep C G; Hermus A R; van der Meer J W
Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids.
Antimicrobial agents and chemotherapy 1992;36(12):2785-9.
1992: Keuter M; Dolmans W M; van der Meer J W
[Traveling when in ill health; advice for travelers with an illness who travel to the tropics]
Nederlands tijdschrift voor geneeskunde 1992;136(52):2573-7.
1992: Gyssens I C; van den Broek P J; Kullberg B J; Hekster Y; van der Meer J W
Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation.
The Journal of antimicrobial chemotherapy 1992;30(5):724-7.
1992: van Deuren M; Santman F W; van Dalen R; Sauerwein R W; Span L F; van der Meer J W
Plasma and whole blood exchange in meningococcal sepsis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(3):424-30.
1992: Kerstens P J; Endtz H P; Meis J F; Oyen W J; Koopman R J; van den Broek P J; van der Meer J W
Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(9):842-7.
1992: Oyen W J; Netten P M; Lemmens J A; Claessens R A; Lutterman J A; van der Vliet J A; Goris R J; van der Meer J W; Corstens F H
Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(7):1330-6.
1992: Oyen W J; Claessens R A; van der Meer J W; Rubin R H; Strauss H W; Corstens F H
Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(5):1110-8.
1992: Blok W L; Vogels M T; Curfs J H; Eling W M; Buurman W A; van der Meer J W
Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice.
The Journal of infectious diseases 1992;165(5):898-903.
1992: Michel M F; van der Meer J W
[A series of articles on infection control]
Nederlands tijdschrift voor geneeskunde 1992;136(14):672-3.
1992: Oyen W J; Claessens R A; van der Meer J W; Corstens F H
Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(3):388-94.
1992: Oyen W J; Claessens R A; Raemaekers J M; de Pauw B E; van der Meer J W; Corstens F H
Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):61-8.
1992: Oyen W J; van Horn J R; Claessens R A; Slooff T J; van der Meer J W; Corstens F H
Diagnosis of bone, joint, and joint prosthesis infections with In-111-labeled nonspecific human immunoglobulin G scintigraphy.
Radiology 1992;182(1):195-9.
1992: Vogels M T; van der Meer J W
Use of immune modulators in nonspecific therapy of bacterial infections.
Antimicrobial agents and chemotherapy 1992;36(1):1-5.
1991: Gyssens I C; Lennards C A; Hekster Y A; Van der Meer J W
Cost of hospital antimicrobial chemotherapy. A method for global cost calculation.
Pharmaceutisch weekblad. Scientific edition 1991;13(6):248-53.
1991: Vercoulen J H; Swanink C M; Galama J M; Fennis J F; van der Meer J W; Bleijenberg G
[Chronic fatigue syndrome. II. Psychosocial hypothesis]
Nederlands tijdschrift voor geneeskunde 1991;135(43):2010-4.
1991: Oyen W J; Claessens R A; van der Meer J W; Corstens F H
Detection of subacute infectious foci with indium-111-labeled autologous leukocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(10):1854-60.
1991: van der Ven A J; Koopmans P P; Vree T B; van der Meer J W
Adverse reactions to co-trimoxazole in HIV infection.
Lancet 1991;338(8764):431-3.
1990: Oyen W J; Claessens R A; van Horn J R; van der Meer J W; Corstens F H
Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(4):403-12.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jos van der Meer

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jos van der Meer (preview)

All Publications